Diabetes tech companies are racing toward ‘fully closed loop’ devices. But automation comes with trade-offs.

The Latest

• 

  Trump further tweaks steel, aluminum, copper tariffs

  A greater range of industrial and agricultural equipment made with the metals will temporarily face a reduced 15% levy starting June 8, per the White House.

  Legal

• 

  Resmed completes $340M Noctrix takeover

  The buyout gives Resmed control of a noninvasive treatment for restless legs syndrome.

  M&A

• 

  Q&A

  Natera’s Solomon Moshkevich on how MRD testing pinpoints cancer recurrence

  Molecular residual disease testing could one day be as ubiquitous as a CT scan, says Natera’s president of clinical diagnostics.

  Diagnostics

• 

  Intuitive elevates Taylor Patton to chief commercial and marketing officer

  Patton’s promotion comes as competition in robotic surgery intensifies, and Intuitive looks to expand its global commercial operations to meet anticipated growth.

  Medical Devices

• 

  Court overturns Insulet’s $59M trade secret verdict against EOFlow

  The U.S. appeals court ruled that Insulet filed the lawsuit too late, considering when it should have learned of the trade secret concerns.

  Diabetes

• 

  California attorney general sues over 23andMe data breach

  The attorney general said the civil penalties could add up to “multiple millions” if the suit is successful.

  Diagnostics

• 

  J&J recalls Impella heart pumps after patient dies

  Johnson & Johnson asked customers to quarantine and return affected products. A spokesperson said J&J conducted quality system audits as part of its integration of Abiomed that resulted in some field actions.

  FDA

• 

  Siemens Healthineers, AiM team up; Procept completes study enrollment

  Siemens Healthineers’ MRI scanners would guide robotic neurosurgeries performed with AiM’s platform. Elsewhere, Procept finished enrollment in a study of its aquablation treatment in prostate cancer.

  Clinical Trials

• 

  Ōura to add blood pressure feature following FDA policy change

  The new wellness tool would alert users to signs of increasing blood pressure. Ōura is studying a separate feature to flag hypertension that would go through the Food and Drug Administration.

  Digital Health

• 

  Cornerstone earns Europe’s CE mark for surgical robot

  CE mark certification comes after Hong Kong-based Cornerstone Robotics raised $200 million in November to accelerate its global expansion.

  Medical Devices

• 

  Abbott receives CE mark for dual glucose-ketone sensor

  Abbott’s first dual-analyte sensor comes as competitors are working to develop their own versions of the technology.

  Diabetes

• 

  AI in medtech is booming. Track new devices here.

  The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of the latest developments in this database.

  Updated May 27, 2026

  AI

• 

  Insulet recalls 7M patch pumps due to leak risk

  The recall is Insulet’s second this year related to tears in the device tubing. So far, 24 serious adverse events have been reported.

  Recalls

• 

  J&J’s DePuy Synthes inks deal to buy orthopedic surgery tech

  The acquisition is the latest in a series of agreements between DePuy Synthes and organizations associated with entrepreneur Stéphane Lavallée.

  M&A

• 

  Dexcom warns of scrapped glucose sensors being resold

  Dexcom has identified two lots of G7 sensors that have been stolen, sold and used by customers.

  Updated May 27, 2026

  Recalls

• 

  Olympus expands in cancer tech with $270M buy of BioProtect

  BioProtect’s balloon spacer device separates the prostate from other structures during cancer radiation.

  M&A

• 

  J&J corrects Impella controller over issue linked to 2 injuries, 1 death

  The controller can stop for about 35 seconds, during which time the patient is unsupported by the heart pump.

  FDA

• 

  Beta Bionics to launch its first insulin patch pump to compete with Insulet

  The device called Mint, which would work with the company’s adaptive insulin dosing algorithm, is expected to debut in the first half of 2027.

  Diabetes

• 

  Ōura files for IPO amid healthcare push

  The smart ring maker’s filing follows a recent $900 million fundraise and comes amid plans to develop more health features for the device.

  Digital Health

• 

  Medtronic to create European software hub in Ireland

  The investment in cardiac digital health will add 85 jobs initially, with more growth expected over the next three years.

  Cardiac

• 

  Intuitive readies 100 updates and improvements for da Vinci 5

  Some updates to Intuitive’s surgical robot aim to improve communication between remote and on-site physicians to expand education opportunities.

  Medical Devices

• 

  Sentante lands Europe’s CE mark for endovascular robot

  The Lithuania-based robotic surgery company is advancing a remote stroke system that was accepted into the FDA’s total product life cycle advisory program earlier this year.

  Medical Devices

• 

  Medtronic to buy SPR Therapeutics for about $650M

  Medtronic would gain a treatment for chronic pain management in its third major acquisition this year.

  M&A

• 

  Stryker’s chief accounting officer to retire

  William Berry Jr. will retire in September, with Corporate Controller Emily Baculik stepping into the role.

  Earnings

• 

  Guardant wins FDA approval for updated liquid biopsy

  The company could secure a higher price for the new test than for its older, narrower product, Wall Street analysts said.

  FDA

More stories